MGAM and Parkinson disease: In addition, the exogenous delivery of miR-124 can inhibit the expression of p62 and p-p38 and attenuate the activation of MG in the SNpc of MPTP-treated mice, thus indicating that miR-124 can inhibit neuroinflammation in the development of PD by targeting p62, p38 (Yao et al., 2019).